Skip to main content Help with accessibility Skip to main navigation

INSULIN DEGLUDEC 100units/mL and 200 units/mL solution for subcutaneous injection (Tresiba®) for type 1 and type 2 diabetes

CCG Approval Status:

Date Added: 27 - Feb - 2020
Body System:
Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of INSULIN DEGLUDEC 100units/mL and 200 units/mL solution for subcutaneous injection (Tresiba®), initiated by specialists only, for type 1 and type 2 diabetes for specific patient groups, taking into account NICE guidance

Static